We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNA icon
251
CNA Financial
CNA
$14.2B
$300K ﹤0.01%
+6,280
New +$289K
LNC icon
252
Lincoln National
LNC
$8.87B
$300K ﹤0.01%
+6,731
New +$280K
DOW icon
253
Dow Inc
DOW
$21.6B
$300K ﹤0.01%
+12,815
New +$295K
WHR icon
254
Whirlpool
WHR
$2.86B
$299K ﹤0.01%
4,151
-1,123
-21% -$82.9K
ES icon
255
Eversource Energy
ES
$27.4B
$299K ﹤0.01%
+4,445
New +$312K
MHK icon
256
Mohawk Industries
MHK
$9.25B
$299K ﹤0.01%
+2,736
New +$314K
BG icon
257
Bunge Global
BG
$21.1B
$299K ﹤0.01%
+3,356
New +$309K
DTE icon
258
DTE Energy
DTE
$29.2B
$299K ﹤0.01%
+2,317
New +$315K
GHC icon
259
Graham Holdings Company
GHC
$4.98B
$299K ﹤0.01%
+272
New +$291K
CBSH icon
260
Commerce Bancshares
CBSH
$8.5B
$299K ﹤0.01%
5,707
+423
+8% +$22.1K
EPR icon
261
EPR Properties
EPR
$4.73B
$299K ﹤0.01%
+5,986
New +$312K
MOS icon
262
The Mosaic Company
MOS
$7.38B
$298K ﹤0.01%
12,389
+3,055
+33% +$82.3K
KNSL icon
263
Kinsale Capital Group
KNSL
$8.57B
$298K ﹤0.01%
+763
New +$311K
AFL icon
264
Aflac
AFL
$63.4B
$298K ﹤0.01%
+2,706
New +$298K
QRVO icon
265
Qorvo
QRVO
$8.69B
$298K ﹤0.01%
+3,529
New +$311K
ADM icon
266
Archer Daniels Midland
ADM
$37.3B
$298K ﹤0.01%
+5,187
New +$310K
CUZ icon
267
Cousins Properties
CUZ
$4.94B
$298K ﹤0.01%
11,566
+2,936
+34% +$76.3K
SWK icon
268
Stanley Black & Decker
SWK
$15.7B
$298K ﹤0.01%
+4,014
New +$283K
SWKS icon
269
Skyworks Solutions
SWKS
$10.5B
$298K ﹤0.01%
+4,701
New +$329K
XP icon
270
XP
XP
$8.35B
$298K ﹤0.01%
+18,204
New +$320K
EXC icon
271
Exelon
EXC
$47.2B
$298K ﹤0.01%
+6,836
New +$312K
DD icon
272
DuPont de Nemours
DD
$19.6B
$298K ﹤0.01%
+2,470
New +$278K
FTI icon
273
TechnipFMC
FTI
$27.2B
$298K ﹤0.01%
+6,683
New +$282K
MTH icon
274
Meritage Homes
MTH
$4.85B
$298K ﹤0.01%
4,522
-1,217
-21% -$84.3K
FULT icon
275
Fulton Financial
FULT
$4.65B
$297K ﹤0.01%
+15,390
New +$283K
9 10
11
12 13

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.